Lutte contre les pénuries de médicaments

This legislative proposal aims to address the growing issue of medicine shortages in France. It seeks to ensure that patients have consistent access to essential treatments by improving the supply chain and reducing dependencies on non-EU production. This will primarily affect pharmaceutical companies, healthcare providers, and patients. It may introduce new requirements for stock management and production transparency to prevent drug deficits.